AHA video: Surgical backup for elective PCI? Randomized trial says no need

Justine Varieur Cadet | | Cardiovascular Business | Patient Care
AHA: C-PORT - 26.16 Mb
Thomas R. Aversano, MD, explained the results of his late-breaking clinical trial, C-PORT, with Cardiovascular Business
ORLANDO, Fla.—Thomas R. Aversano, MD, prinicipal investigator of C-PORT, spoke with Cardiovascular Business about his randomized trial, which evaluated the safety of elective PCI in higher volume facilities with and without surgical backup. The findings were presented as a late-breaking clinical trial Nov. 14 at the 2011 American Heart Association conference.

Aversano discussed the outcomes, which showed no difference between the two types of facilities, but also the wider implications of the healthcare. He also hinted at the future results of this ongoing study with its quality of life and cost-effectiveness evaluations.

This video was conducted collaboratively with ClinicalTrialResults.org.

 

 

Justine Varieur Cadet

Related Content

Early pregnancy blood pressure patterns tied to hypertension risk years later
Enabling X-ray-free ablation procedures in the EP lab
Detecting coronary inflammation on CT imaging could reshape preventive cardiology
Know your options: What cardiologists recommend when alternative access is required for TAVR
New drug therapies targeting Lp(a) could be a breakthrough in cardiovascular care
Getinge ending production of cardiopulmonary surgical perfusion systems

Around the web

Radiology Business
The impact of Trump tariffs on iodine contrast media costs

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.